Sign in to view content

Association Between Dysfunctional Complement Factor I: Rare Variant Status and Progression to Advanced AMD Outcomes

Johanna M. Seddon, MD, ScM, FARVO, FASRS

Video
Published 2022

Related

Baseline Characteristics in the Phase 2 GOLDEN Study of IONIS-FB-LRx, an Investigational Antisense Oligonucleotide Designed to Treat AMD-Associated Geographic Atrophy
Glenn J. Jaffe, MD
Annual Meeting Talks
2022
Cell Therapies for Atrophic AMD
Allen C Ho, MD FASRS
Updates from the Field
2020
Vitreoretinal Interface Disease In the Setting of AMD
Andrew A. Moshfeghi, MD, MBA, FASRS
Updates from the Field
2019

Category: AMD-Non-Neovascular

See more